Fluconazole in visceral leishmaniasis

Indian Pediatrics

Volumn 35, Issue 3, 1998, Pages 268-269

  Jha, B B ^a  

^a Dist Sadar Chils Specialist Hosp   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; VISCERAL LEISHMANIASIS;

ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUCONAZOLE; HUMANS; INDIA; LEISHMANIASIS, VISCERAL; MALE; TREATMENT OUTCOME;

EID: 0031899812     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Dutta M, Ghosh TK. Review of the current status of Leishmaniasis epidemiology, In: Proceedings of the Indo-UK Workshop on Leishmaniasis, New Delhi, Indian Council of Medical Research, 1983; pp 97-102.
2. Government of India, Report on Control of the Leishmaniasis. Kala Azar in Bihar. New Delhi, Department of Health and Family Welfare, 1991.
3. World Health Organization. Visceral Leishmaniasis. WHO Technical Report Series No. 793. Geneva, World Health Organization.
4. Thakur CP, Kumar M, Kumar P, Mishra BN, Pandey AK. Rationalization of regimens of treatment of Kala Azar with sodium stibogluconate in India: A randomized study. BMJ 1988; 296: 155-156.
5. Thakur CP. Diminishing effectiveness of currently used drugs in treatment of Kala Azar and Amphotericin B in Antimony and Pentamidine resistant Kala Azar. In: Current Trends in Leishmania Research. Eds. Bhaduri AN, Basu MK, Sen AK, Kumar S. New Delhi, Council of Scientific and Industrial Research, 1993; pp 254-261.
6. Sunder S. Recent advances in the treatment of visceral leishmaniasis. J Intern Med 1994; 7: 7-9.
7. Sunder S, Singh VP. Agrawal NK, Murray HW. Treatment of Kala Azar with oral fluconazole. Lancet 1996; 348: 614.